This is a written testimony from 2017 presented to Congress by experts in the Department of Health and Human Services outlining the steps the department has taken to advance the goals of the Opioid Strategy. This document presents how leaders at SAMHSA, CDC, NIH, and FDA bring unique expertise and capabilities that enable HHS to take a comprehensive, complementary, and flexible approach to the opioid crisis.